1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Dimerix Limited
  6. News
  7. Summary
    DXB   AU000000DXB7

DIMERIX LIMITED

(DXB)
Delayed Australian Stock Exchange  -  05/20 01:31:00 am EDT
0.1450 AUD   +3.57%
05/08Dimerix Secures US FDA Approval for Phase 3 Kidney Trial; Shares Rise 4%
MT
05/08Dimerix Limited Announces Approval of Action3 Phase 3 Clinical Trial of DMX-200 in FSGS
CI
04/26DIMERIX : Quarterly Appendix 4C and Activities Report
PU
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Dimerix Secures Australian Ethics Approval for Phase 3 Study of COVID-19 Drug Candidate; Shares Jump 7%

12/22/2021 | 10:39pm EDT


© MT Newswires 2021
All news about DIMERIX LIMITED
05/08Dimerix Secures US FDA Approval for Phase 3 Kidney Trial; Shares Rise 4%
MT
05/08Dimerix Limited Announces Approval of Action3 Phase 3 Clinical Trial of DMX-200 in FSGS
CI
04/26DIMERIX : Quarterly Appendix 4C and Activities Report
PU
03/28Dimerix Receives $3 Million Tax Rebate; Shares Rise 3%
MT
02/28DIMERIX : Investor Call and Presentation
PU
02/27Dimerix Limited Announces DSMB Change to REMAP-CAP COVID-19 Study
CI
02/23DIMERIX : Half-Year Financial Report & Appendix 4D - 31 December 2021
PU
02/23Dimerix Limited Reports Earnings Results for the Half Year Ended December 31, 2021
CI
02/06Dimerix Names New Chief Medical Officer
MT
02/06Dimerix Limited Appoints Dr. Ash Soman as Chief Medical Officer
CI
More news
Financials
Sales 2021 4,44 M 3,12 M 3,12 M
Net income 2021 -6,37 M -4,48 M -4,48 M
Net cash 2021 0,16 M 0,11 M 0,11 M
P/E ratio 2021 -6,06x
Yield 2021 -
Capitalization 46,5 M 32,7 M 32,7 M
EV / Sales 2020 26,7x
EV / Sales 2021 8,66x
Nbr of Employees -
Free-Float 73,5%
Chart DIMERIX LIMITED
Duration : Period :
Dimerix Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DIMERIX LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Nina Webster Chief Executive Officer, MD & Director
Hamish George Chief Financial Officer & Secretary
James Howard Williams Non-Executive Chairman
David Packham Chief Medical Officer
Robert Shepherd Director-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
DIMERIX LIMITED-40.82%33
MODERNA, INC.-46.35%54 195
LONZA GROUP AG-27.84%41 796
IQVIA HOLDINGS INC.-28.46%38 202
SEAGEN INC.-9.68%25 704
ICON PUBLIC LIMITED COMPANY-30.22%17 567